MAPK14 and neoplasm: These two studies focused on lung stem cell or cancer stem cell differentiation in response to p38α MAP kinase pathway and claimed that p38α MAP kinase inactivity by using p38 MAP kinase inhibitors impaired lung stem cell differentiation and increased the tumor susceptibility [16], [23].